510(k) · Cleared
ClearedOrthoSteady G Bone Cement
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
G21, S.R.L. · LOD Bone Cement
Cleared on Mar 6, 2018 as substantially equivalent to K031673 (Heraeus Kulzer GmbH & Co. KG, 2004) and 1 other predicate after a 113-day review. Its family tree reaches back 5 generations to 1984. 2 later devices descend from it.
- Decided
- Mar 6, 2018
- Review
- 113 days
- Class
- Class II
- Product code
- LOD
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 5 generations to P810020 (1984). 10 ancestors in all. 2 later devices descend from it, 2 citing it directly.
- Root · 5 generations backP810020 Palacos R Bone CementSmith & Nephew Richards, Inc. · 1984 · Recalled
- 4 generations backK023012 Smartset HV Bone CementDePuy Orthopaedics, Inc. · 2003
- 3 generations backK033563 Smartset GHV Gentamicin Bone CementDePuy Orthopaedics, Inc. · 2004 · Recalled
- 2 generations backK041656 Modification to Depuy 1 Gentamicin Bone Cement and Smartset GMV…DePuy Orthopaedics, Inc. · 2004
- 1 generation backK053002 Depuy CMW 1 Gentamicin Bone CementDePuy Orthopaedics, Inc. · 2005
- This deviceK173494 OrthoSteady G Bone CementG21, S.R.L. · 2018
- Descendant · cites it directly · 0 of its ownK193061 G3 40 Radiopaque Bone CementG21, S.R.L. · 2020
- Descendant · cites it directly · 0 of its ownK193059 G1 40 Radiopaque Bone CementG21, S.R.L. · 2020
Most influential descendants
Showing 2 of 2 · See allView FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | P810020 | Palacos R Bone Cement | Smith & Nephew Richards, Inc. | 1984 | 1 |
| −4 | K023012 | Smartset HV Bone Cement | DePuy Orthopaedics, Inc. | 2003 | — |
| −3 | K033563 | Smartset GHV Gentamicin Bone Cement | DePuy Orthopaedics, Inc. | 2004 | 1 |
| −2 | K041656 | Modification to Depuy 1 Gentamicin Bone Cement and Smartset GMV Endurance… | DePuy Orthopaedics, Inc. | 2004 | — |
| −1 | K053002 | Depuy CMW 1 Gentamicin Bone Cement | DePuy Orthopaedics, Inc. | 2005 | — |
| 0 (this device) | K173494 | OrthoSteady G Bone Cement | G21, S.R.L. | 2018 | — |
| +1 | K193061 | G3 40 Radiopaque Bone Cement | G21, S.R.L. | 2020 | — |
| +1 | K193059 | G1 40 Radiopaque Bone Cement | G21, S.R.L. | 2020 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 2003 | 2 | 0 |
| 2004 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2020 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in LOD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new LOD device
- #1 K254107 Refobacin Bone Cement R (110034355)score 11.8 · 3 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K031673 | Refobacin -Palacos GSummary page 4…9, 2018 OrthoSteady G Bone Cement Bone Cement, Antibiotic 888.3027 - PMMA bone cement Class I LOD MBB PALACOS R+G Bone Cement device (Heraeus Kulzer GMBH & Co. KG) — K031673 Additional DePuy CMWTM 1 Gentamicin Bone Cement (DePuy Orthopaedics) - K053002 Indication for Use: Indications for use/Intend… | 2004 |
| * | K053002 | Depuy CMW 1 Gentamicin Bone CementSummary page 4…ement Class I LOD MBB PALACOS R+G Bone Cement device (Heraeus Kulzer GMBH & Co. KG) — K031673 Additional DePuy CMWTM 1 Gentamicin Bone Cement (DePuy Orthopaedics) - K053002 Indication for Use: Indications for use/Intended Use Page 1 K173494 Page 2 of 3 OrthoSteady G Bone Cement is… | 2005 |
What descends from it? (2)
2 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 34 years and passes through 3 companies; a new generation was cleared every 1.4 years on median.
- 4 of the 10 ancestors have a recall of any class.
- Of its descendants, K193061 (G21, S.R.L., 2020) has gone furthest, with 0 descendants of its own.
- 8 other devices also cite its predicate K031673.
How does its category compare?
All LOD devicesLOD Bone Cement: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.
FDA decisions per year · LOD
1in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · LOD
277in 2022
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · LOD
2in 2022
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · LOD
355in 2025
MAUDE reports naming product code LOD, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 78 |
| 2008 | 1 | — | 0 | 134 |
| 2009 | 3 | 103 | 0 | 170 |
| 2010 | 0 | — | 0 | 291 |
| 2011 | 0 | — | 0 | 428 |
| 2012 | 0 | — | 0 | 412 |
| 2013 | 2 | — | 0 | 501 |
| 2014 | 1 | — | 1 | 465 |
| 2015 | 4 | 138 | 0 | 529 |
| 2016 | 1 | — | 0 | 615 |
| 2017 | 3 | 96 | 4 | 817 |
| 2018 | 2 | — | 0 | 1,295 |
| 2019 | 4 | 90 | 0 | 2,307 |
| 2020 | 3 | 139 | 1 | 1,294 |
| 2021 | 4 | 95 | 0 | 782 |
| 2022 | 3 | 277 | 2 | 472 |
| 2023 | 2 | — | 0 | 475 |
| 2024 | 1 | — | 0 | 492 |
| 2025 | 1 | — | 0 | 355 |
| 2026 | 1 | — | 2 | — |
What is it indicated for?
OrthoSteady G Bone Cement is indicated for use in the second stage of a two-stage revision for total joint arthroplasty after the initial infection has been cleared.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K173494 · printed Nov 6, 2026
Cite this page
510(k) Report. “K173494: OrthoSteady G Bone Cement.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K173494
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026